Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

Severe Strongyloides stercoralis, such as hyperinfection syndrome, carries a high mortality risk. Even with appropriate treatment, patients may experience infectious complications and failure of therapy. Currently, there are no Food and Drug Administration–approved parenteral therapies available for...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Case Rep
Autori principali: Zeitler, Kristen, Jariwala, Ripal, Restrepo-Jaramillo, Ricardo, Kapadia, Shyam, Casanas, Beata, Alrabaa, Sally, Sriaroon, Chakrapol
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2018
Soggetti:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990086/
https://ncbi.nlm.nih.gov/pubmed/29866667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223138
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi